Word: novelizes
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...pronounce - running from the relatively phonetic Magnalroxate to the tongue-cramping Hnegripitrom. The students were then told to rank the additives according to how dangerous they believed they were to consume. As the researchers suspected, the more challenging it was to say a chemical's name, the more novel - and less safe - it was thought...
...Medgar W. Evers in addition to Houston. Though a more general release celebration occurred in New York City, Saturday’s Cambridge event, held in the Zero Arrow Theatre, focused specifically on Law School graduate Houston. Born in 1895, Houston served as the NAACP Litigation Director, pioneering a novel legal strategy for confronting the institionalized racism of the United States’ Jim Crow Laws. As dean of Howard University Law School, Houston trained a generation of young black lawyers, including future Supreme Court Justice Thurgood Marshall. In 2005, HLS established the Charles Hamilton Houston Institute for Race & Justice...
...Yates' daughter Monica, 51, who lives near Flint, Michigan, is understandably happy with the turn of events. "A 48-year-old novel, having a life, which it never had in the first place!" she says enthusiastically. "It's excellent." She's not really surprised that the book has found an audience, though. "I never doubted, and I don't even think he really doubted." But, she adds, "He would have liked to have it before he died." (See Time's Top 10 Fiction Books...
Layoffs at big companies are so common now that it is novel when a day goes by without Microsoft (MSFT), Caterpillar (CAT), or Macy's (MC) letting thousands of people go. There are a relatively small number of America's largest companies which will almost certainly not have significant layoffs. One of them might close an office in Turkey, another could replace telephone operators with an automated system, but each is in a unique position that makes it highly unlikely for them to want or need to fire employees...
...Amgen (AMGN) is still growing rapidly unlike most Big Pharma companies. Its biotech business is producing novel medical treatments that have kept Amgen's sales solid while old line drug companies have been shrinking. In the fourth quarter, Amgen spent $770 million on R&D and needs to do so to both further refine and develop new drugs. The firm is not cutting back on the essentials for keeping its product mix strong simply because the economy is weak. Amgen expects to bring in $15 billion in revenue this year, about flat with 2008. Amgen has several products in trials...